1. Home
  2. RGEN

RGEN

Repligen Corporation

Logo Repligen Corporation

Health Care

Medical/Dental Instruments

Nasdaq

as 04-12-2024 10:30am EST

$
-
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

Founded: 1981 Country:
United States
United States
Employees: N/A City: WALTHAM
Market Cap: 9.8B IPO Year: N/A
Target Price: $199.00 AVG Volume (30 days): 539.2K
Analyst Decision: Strong Buy Number of Analysts: 9
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 0.74 EPS Growth: -77.16
52 Week Low/High: $110.45 - $211.13 Next Earning Date: 04-30-2024
Revenue: $638,764,000 Revenue Growth: -20.31%
Revenue Growth (this year): 1.64% Revenue Growth (next year): 16.35%

Share on Social Networks: